Augmedix, Inc.
AUGXDelisted Oct 2, 2024- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001769804
Augmedix, Inc. was delisted on Oct 2, 2024; its insiders filed their last Form 4 on Oct 4, 2024; 45 institutions reported holding it in 13F filings for Q3 2024, worth $84.4M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 45
- Q3 2024, −6 vs. previous quarter
- 13F value
- $84.4M
- Reported value at the end of Q3 2024
- Superinvestors holding
- 0
- At the end of Q3 2024
Superinvestors holding AUGX, Q3 2024
No superinvestor reported holding AUGX at the end of Q3 2024.
Latest insider trades
Open-market purchases and sales by Augmedix, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 (view filing) | May 15 | 2 days | Ginocchio PaulCHIEF FINANCIAL OFFICER | SSale | −2.35K | $1.19 | −$2.80K | −1.8%131.9K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Chatterjee SauravCHIEF TECHNOLOGY OFFICER | SSale | −1.77K | $1.19 | −$2.10K | −37.7%2.92K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Shakil IanCHIEF STRATEGY OFFICER | SSale | −1.39K | $1.19 | −$1.65K | −20.5%5.36K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Krakaris EmmanuelPRESIDENT, CEO, AND SECRETARY | SSale | −3.53K | $1.19 | −$4.20K | −5.7%58.9K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Breber SandraCHIEF OPERATING OFFICER | SSale | −2.35K | $1.19 | −$2.80K | −12.6%16.4K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Hawkins JonathanCHIEF REVENUE OFFICER | SSale | −1.77K | $1.19 | −$2.10K | −37.7%2.92K after | 10b5-1 |
| Apr 16, 2024 (view filing) | Apr 15 | 1 day | Shakil IanCHIEF STRATEGY OFFICER | SSale | −500 | $3.80 | −$1.90K | −14.3%3.00K after | 10b5-1 |
| Apr 15, 2024 (view filing) | Apr 12 | 3 days | Shakil IanCHIEF STRATEGY OFFICER | SSale | −19.5K | $3.82 | −$74.7K | −86.7%3.00K after | 10b5-1 |
| Apr 11, 2024 (view filing) | Apr 9-11 | 2 days | Shakil IanCHIEF STRATEGY OFFICER | SSale | −92.8K | $3.98 | −$369.1K | −96.9%3.00K after | 3 lots10b5-1 |
| Apr 9, 2024 (view filing) | Apr 5-8 | 4 days | Shakil IanCHIEF STRATEGY OFFICER | SSale | −89.2K | $4.00 | −$357.1K | −96.7%3.00K after | 3 lots10b5-1 |
Top 10 13F holders, Q3 2024
The largest institutional positions in Augmedix, Inc. at the end of Q3 2024; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmile Group, LLC | 16,380,327 | $38.5M | 2.27% | 00.0% | Unchanged |
| Beryl Capital Management LLC | 4,492,772 | $10.6M | 2.28% | +4,492,772 | New |
| Oddo BHF Asset Management SAS | 2,425,000 | $5.70M | 0.28% | +2,425,000 | New |
| Samjo Management, LLC | 1,799,000 | $4.23M | 1.46% | −2,881,900−61.6% | Reduced |
| Vanguard Group Inc | 1,589,255 | $3.73M | 0.00% | +177,000+12.5% | Added |
| Gabelli Funds LLC | 1,247,622 | $2.93M | 0.02% | +1,247,622 | New |
| Trium Capital LLP | 1,182,119 | $2.78M | 1.28% | +1,182,119 | New |
| Gabelli & Co Investment Advisers, Inc. | 1,013,150 | $2.38M | 0.41% | +1,013,150 | New |
| HGC Investment Management Inc. | 825,424 | $1.94M | 0.80% | +825,424 | New |
| Russell Investments Group, Ltd. | 664,306 | $1.56M | 0.00% | +14,988+2.3% | Added |